Hutom , an artificial intelligence (AI)-based surgical support solution company, and Livesmed, a company specializing in multi-joint laparoscopic surgical instruments and surgical robots, announced on the 5th that they have signed a memorandum of understanding (MOU) for technological cooperation and joint business promotion.
Through this agreement, both companies will combine their core technologies to build a next-generation surgical environment and enhance their competitiveness in the global market. The scope of the collaboration includes joint research and development, marketing, academic events, and personnel exchange.
Hutom is developing an integrated platform that leverages AI and 3D imaging technology to support preoperative planning, intraoperative navigation, and postoperative data analysis. Its core solution, the "RUS (Surgical Navigation Platform)," transforms 2D CT images into 3D anatomical models and provides port placement and navigation capabilities for laparoscopic and endoscopic surgeries. Its efficiency and safety have been proven in major domestic general hospitals.
LivsMed is developing the "ArtiSential," a multi-joint laparoscopic surgical instrument capable of 90-degree rotation, both vertically and horizontally, and the "STARK," a cutting-edge laparoscopic surgical robot. An ultra-long-distance telesurgery experiment using STARK was successfully conducted in the United States in July 2025.
Hutom CEO Hyung-jin Jin said, “The combination of Livesmed’s cutting-edge surgical instruments and Hutom’s AI technology will improve surgical precision and efficiency,” adding, “Through this agreement, we will secure global medical technology competitiveness.”
“The collaboration between our two companies will lead to the development of innovative solutions needed in the medical field,” said Bae Dong-hwan, managing director of Livesmed. “Through continued collaboration, we will elevate the status of Korean medical technology.”
- See more related articles
You must be logged in to post a comment.